Real-World Evidence
Tonix Pharmaceuticals to Present Real-World Data on Fibromyalgia Treatment at ISPOR 2026
Tonix Pharmaceuticals will present findings from a retrospective cohort study on fibromyalgia treatment patterns using U.S. claims data, offering insights into real-world usage following the launch of its newly approved drug TONMYA.
American Heart Association Launches Major Initiative to Address Treatment Gaps in Common Heart Failure Types
The American Heart Association's new three-year IMPLEMENT-EF initiative aims to improve care for the 75% of heart failure patients with preserved or mildly reduced ejection fraction, addressing significant evidence gaps through multidisciplinary team approaches and real-world data analysis.
Fifty 1 Labs Subsidiary Publishes Key Oncology Real-World Evidence Research
Fifty1 AI Labs' publication on transportability methods in oncology real-world evidence demonstrates how AI-driven frameworks can bridge data gaps and improve global access to life-saving therapies in a market projected to reach $3.51 billion by 2035.